efpia.eu
EFPIA - EU-Vietnam FTA Will Boost Bilateral Trade and Speed Patient Access to Medicines
http://efpia.eu/mediaroom/290/43/EU-Vietnam-FTA-Will-Boost-Bilateral-Trade-and-Speed-Patient-Access-to-Medicines
Press Releases and Statements. EU-Vietnam FTA Will Boost Bilateral Trade and Speed Patient Access to Medicines. EFPIA lauds the excellent work undertaken by the Commission during two and a half years of intense negotiations and understands that the agreement in principle offers EU pharmaceutical manufacturers a level playing field in Vietnam, while promoting wider and faster patient access to innovative medicines. EFPIA also notes Vietnam’s commitments concerning the procurement of pharmaceutical product...
efpia.eu
EFPIA - EFPIA Annual Report 2014
http://efpia.eu/documents/140/61/EFPIA-Annual-Report-2014
EFPIA Annual Report 2014. Click here to see the flipbook. Published on 02 June 2015. The Pharmaceutical Industry in a Global Economy: What Drives EU Exports of Pharmaceuticals Overseas. Since 2001, EFPIA has collaborated with the College of Europe to establish the EFPIA Award , created with the aim of highlighting a Master’s Thesis covering . Read more. Follow us on Twitter. Add us on Google Plus. Check us out on Pinterest. Rue du Trône 108. Tel: 32 (0)2 626 25 55. Design by Morris and Chapman.
efpia.eu
EFPIA - Innovation has never been as exciting or challenging as it is today
http://efpia.eu/topics/innovation
Innovation has never been as exciting or challenging as it is today. Innovation is the core of our industry. The solutions offered by innovative medicines can help keep people healthier for longer. Innovation also allows healthcare systems to be more sustainable, with innovative medical technologies cutting down costs and waiting times. In 2011, the industry invested 27.5 billion in R&D. Cuts, Cuts, Cuts! But what about innovation? Richard Bergström, EFPIA Director General. Follow us on Twitter.
efpia.eu
EFPIA - Topics
http://efpia.eu/topics
Health is at the heart of Europe’s economic and social prosperity. Investing in innovation in Europe benefits the EU economy, as well as the health of its population. New and improved medicines support patient wellbeing by reducing inequalities in health and improving patient safety. Ensuring patient access to these medicines is a must. Finding healthcare solutions to meet varied national healthcare needs and budgets helps ensure equal patient care across the EU. Follow us on Twitter. Rue du Trône 108.
efpia.eu
EFPIA - EMVO Efforts against Falsified Medicines Invigorated by Appointment of New President
http://efpia.eu/mediaroom/287/43/EMVO-Efforts-against-Falsified-Medicines-Invigorated-by-Appointment-of-New-President
Press Releases and Statements. EMVO Efforts against Falsified Medicines Invigorated by Appointment of New President. Four months after its official establishment in February this year, the European Medicines Verification Organisation (EMVO) has appointed a new President. Designated to the post on June 19, Sonia Ruiz Moran replaced John Chave, former Secretary General of Pharmaceutical Group of the European Union (PGEU). Sonia holds an MBA from the University of Salamanca in addition to a degree in Law an...
efpia.eu
EFPIA - EFPIA Letter to Health Commissioner Andriukaitis on the Greek Economic Crisis
http://efpia.eu/mediaroom/281/44/EFPIA-Letter-to-Health-Commissioner-Andriukaitis-on-the-Greek-Economic-Crisis
EFPIA Letter to Health Commissioner Andriukaitis on the Greek Economic Crisis. On 29 June EFPIA sent a letter on the Greek situation to Commissioner Andriukaitis, Commissioner for Health, with copy to Commissioners Bienkowska (Internal Market, Industry, Entrepreneurship, SMEs), Katainen (Vice-President for Jobs, Growth, Investment and Competitiveness), Moscovici (Economic and Financial Affairs, Taxation and Customs), Vestager (Competition) and relevant Directorate General Directors and Heads of Units.
transparency.efpia.eu
EFPIA - Responsible Transparency: Media Room
http://transparency.efpia.eu/mediaroom/24/19/International-clinical-trials-day-a-day-to-celebrate
International clinical trials day a day to celebrate. Marks international Clinical Trials Day, a time to recognise the contribution of the many thousands of trial participants, researchers, companies, sponsors, journals, registries and regulators across Europe that have contributed to some remarkable, life-changing advances in modern medicine, in recent years. EPFIA/PhRMA principles for responsible sharing of clinical trial data. While clinical trials are evolving with new approaches, technologies and de...
transparency.efpia.eu
EFPIA - The EFPIA Code
http://transparency.efpia.eu/the-efpia-code-2
EFPIA CODE ON DISCLOSURE OF TRANSFERS OF VALUE FROM PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS. Adopted by the EFPIA Statutory General Assembly of 24 June 2013, and requiring implementation in national codes by 31 December 2013 - FINAL EDITED VERSION Following General Assembly Approval. Healthcare professionals and healthcare organisations with whom they work provide the pharmaceutical industry with valuable, independent and expert knowledge derived from their clini...
